All ProductsDisplaying Products by Catalog Number (3400 - 3499)
010002000300040005000600070008000900100011001200130014001500160017001800190020002100220023002400250026002700280029003000310032003300340035003600370038003900400041004200430044004500460047004800490050005100520053005400550056005700580059006000610062006300640065006600670068006900700071007200
| Cat. No. | Product Name / Activity |
|---|---|
| 3400 | RuBi-GABA |
| Caged GABA; excitable at visible wavelengths | |
| 3401 | Vinorelbine ditartrate |
| Selective mitotic microtubule antagonist | |
| 3402 | Tubacin |
| HDAC6 inhibitor; inhibits a-tubulin deacetylation | |
| 3404 | S 32826 |
| Potent autotaxin inhibitor | |
| 3405 | COG 133 |
| ApoE peptide fragment | |
| 3406 | GLYX 13 |
| NMDA partial agonist; acts at the glycine site | |
| 3407 | R 715 |
| Potent and selective B1 antagonist | |
| 3409 | BMS 453 |
| Synthetic retinoid and RARβ agonist; also RARα and RARγ antagonist | |
| 3410 | BMS 961 |
| Selective RARγ agonist | |
| 3411 | SR 11237 |
| Pan RXR agonist | |
| 3412 | (Z)-4-Hydroxytamoxifen |
| Metabolite of tamoxifen (Cat. No. 0999) | |
| 3413 | YM 202074 sesquifumarate |
| High affinity, selective mGlu1 antagonist | |
| 3414 | FAK Inhibitor 14 |
| Selective FAK inhibitor | |
| 3415 | DMPO |
| Nitric oxide spin trap; measure oxygen-centered free radicals | |
| 3416 | Tris DBA |
| N-myristoyltransferase-1 inhibitor; antiproliferative | |
| 3417 | CP 99994 dihydrochloride |
| High affinity NK1 antagonist | |
| 3418 | Amylin |
| Endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptors | |
| 3419 | AC 187 |
| Potent and selective amylin antagonist | |
| 3420 | SHU 9119 |
| MC3 and MC4 antagonist; MC5 partial agonist | |
| 3422 | [D-Phe12,Leu14]-Bombesin |
| Bombesin receptor antagonist | |
| 3424 | γ1-MSH |
| Selective MC3 receptor agonist | |
| 3425 | M40 |
| Potent, non-selective galanin receptor antagonist | |
| 3426 | JKC 363 |
| Potent and selective MC4 receptor antagonist | |
| 3427 | Oncrasin 1 |
| Induces abnormal nuclear aggregation of PKCι; proapoptotic | |
| 3429 | 4-IPP |
| Inhibitor of macrophage migration inhibitory factor (MIF); suicide substrate | |
| 3430 | CFTRinh 172 |
| Voltage-independent, selective CFTR chloride channel blocker | |
| 3432 | S 25585 |
| Potent and selective NPY Y5 receptor antagonist | |
| 3433 | GSK 0660 |
| Selective PPARδ antagonist | |
| 3434 | [Ala17]-MCH |
| Potent MCH receptor agonist | |
| 3435 | Insulin (human) recombinant expressed in yeast |
| Endogenous peptide agonist | |
| 3436 | [D-Trp34]-Neuropeptide Y |
| Potent NPY Y5 agonist; orexigenic | |
| 3438 | MCL 0020 |
| Selective MC4 receptor antagonist | |
| 3439 | NH 125 |
| CaM kinase III (eEF-2 kinase) inhibitor | |
| 3440 | SID 7969543 |
| Selective steroidogenic factor-1 (SF-1, NR5A1) inhibitor | |
| 3489 | Astemizole |
| Orally active, potent H1 antagonist; also KV11.1 (hERG) channel blocker | |
| 3490 | UCPH 101 |
| Selective non-substrate EAAT1 inhibitor | |
| 3491 | Prion Protein 106-126 (human) |
| Prion protein fragment | |
| 3492 | ACTH (1-39) |
| Potent endogenous MC2 agonist | |
| 3493 | Cyclosomatostatin |
| Non-selective sst antagonist | |
| 3495 | Fludarabine |
| Purine analog; inhibits DNA synthesis | |
| 3496 | BX 471 |
| Potent, selective CCR1 antagonist | |
| 3497 | TRAP-6 |
| PAR1 peptide fragment (residues 42-47); acts as a PAR1 agonist | |
| 3498 | RGDS peptide |
| Integrin binding sequence; inhibits integrin receptor function | |
| 3499 | ML 10302 hydrochloride |
| Potent and selective 5-HT4 partial agonist |